FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025127953> ?p ?o ?g. }

• W2025127953 endingPage "226" @default.
• W2025127953 startingPage "213" @default.
• W2025127953 abstract "Best Supportive Care (BSC) is the treatment of choice when cure is not achievable with anticancer treatments and involves management of disease-related symptoms. In the palliative treatment of non-small cell lung cancer (NSCLC) radiation therapy has for a long time been the cornerstone of symptom management, although the best schedule is still to be defined. Chemotherapy, on the other hand, has been excluded from classical definitions of BSC and has been reserved only for selected patient populations in which a survival benefit was demonstrated using cisplatin-based regimens. We reviewed randomized trials on both palliative radiotherapy and chemotherapy in order to assess the impact of anticancer treatments on quality of life in advanced NSCLC patients. While no randomized trials compared radiation therapy with a control arm not including it, several randomized trials assessed the use of different schedules. Hypofractionated schedules seem to have comparable palliative activity when compared with the standard fractionated regimens, at least in metastatic, poor-prognosis patients. In locally advanced, inoperable NSCLC higher radiation doses administered with conventional fractionation achieve better results in terms of local control and survival. The rate of palliation of local symptoms is high, being 60-80% for chest pain and hemoptysis, while breathlessness and cough are controlled at a somewhat lower rate (50-70%). General symptoms (fatigue, anorexia, and depression) are affected in a minority of patients. Chemotherapy was compared with BSC in several randomized trials, in some of which an analysis of the quality of life was included. Results are consistent in favor of its palliative role and, when local symptom control is assessed, rates of palliation seem similar to those achieved by radiation. Benefits apply to metastatic NSCLC patients with good performance status, low body weight loss, age below 70-75. However, some studies support the use of chemotherapy also in patients with poor prognostic features. A comparison in terms of quality of life and symptom palliation between different chemotherapy regimens is the object of few trials. Both chemotherapy and radiation have an important role in the palliative treatment of advanced NSCLC patients and should be included in BSC programs. Future randomized trials should assess the best way of combining these two approaches." @default.
• W2025127953 created "2016-06-24" @default.
• W2025127953 creator A5015046932 @default.
• W2025127953 creator A5047937377 @default.
• W2025127953 creator A5056829099 @default.
• W2025127953 date "2001-06-01" @default.
• W2025127953 modified "2023-10-16" @default.
• W2025127953 title "Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?" @default.
• W2025127953 cites W1483985834 @default.
• W2025127953 cites W1748441280 @default.
• W2025127953 cites W1837121308 @default.
• W2025127953 cites W1839238860 @default.
• W2025127953 cites W1848316250 @default.
• W2025127953 cites W1856909224 @default.
• W2025127953 cites W1868450210 @default.
• W2025127953 cites W1922104747 @default.
• W2025127953 cites W1930978022 @default.
• W2025127953 cites W1933707312 @default.
• W2025127953 cites W1961110209 @default.
• W2025127953 cites W1964155392 @default.
• W2025127953 cites W1966760280 @default.
• W2025127953 cites W1967832506 @default.
• W2025127953 cites W1968765750 @default.
• W2025127953 cites W1975283545 @default.
• W2025127953 cites W1979621990 @default.
• W2025127953 cites W1982864024 @default.
• W2025127953 cites W1984733361 @default.
• W2025127953 cites W1986335982 @default.
• W2025127953 cites W1998476161 @default.
• W2025127953 cites W2003562529 @default.
• W2025127953 cites W2003574138 @default.
• W2025127953 cites W2014145691 @default.
• W2025127953 cites W2017062373 @default.
• W2025127953 cites W2017217585 @default.
• W2025127953 cites W2018089902 @default.
• W2025127953 cites W2039429525 @default.
• W2025127953 cites W2051767374 @default.
• W2025127953 cites W2062390843 @default.
• W2025127953 cites W2062569567 @default.
• W2025127953 cites W2064680538 @default.
• W2025127953 cites W2067719172 @default.
• W2025127953 cites W2076694849 @default.
• W2025127953 cites W2076773100 @default.
• W2025127953 cites W2077210792 @default.
• W2025127953 cites W2085143406 @default.
• W2025127953 cites W2090558521 @default.
• W2025127953 cites W2091693402 @default.
• W2025127953 cites W2124997388 @default.
• W2025127953 cites W2128715012 @default.
• W2025127953 cites W2130652363 @default.
• W2025127953 cites W2133852635 @default.
• W2025127953 cites W2137959107 @default.
• W2025127953 cites W2146014573 @default.
• W2025127953 cites W2155053061 @default.
• W2025127953 cites W2162444964 @default.
• W2025127953 cites W2312703485 @default.
• W2025127953 cites W2607182122 @default.
• W2025127953 cites W4239714259 @default.
• W2025127953 cites W4244503053 @default.
• W2025127953 cites W4251309185 @default.
• W2025127953 doi "https://doi.org/10.1016/s0169-5002(00)00222-1" @default.
• W2025127953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11390003" @default.
• W2025127953 hasPublicationYear "2001" @default.
• W2025127953 type Work @default.
• W2025127953 sameAs 2025127953 @default.
• W2025127953 citedByCount "42" @default.
• W2025127953 countsByYear W20251279532014 @default.
• W2025127953 countsByYear W20251279532015 @default.
• W2025127953 countsByYear W20251279532016 @default.
• W2025127953 countsByYear W20251279532018 @default.
• W2025127953 countsByYear W20251279532023 @default.
• W2025127953 crossrefType "journal-article" @default.
• W2025127953 hasAuthorship W2025127953A5015046932 @default.
• W2025127953 hasAuthorship W2025127953A5047937377 @default.
• W2025127953 hasAuthorship W2025127953A5056829099 @default.
• W2025127953 hasConcept C126322002 @default.
• W2025127953 hasConcept C143998085 @default.
• W2025127953 hasConcept C159110408 @default.
• W2025127953 hasConcept C168563851 @default.
• W2025127953 hasConcept C2776256026 @default.
• W2025127953 hasConcept C2776694085 @default.
• W2025127953 hasConcept C2779951463 @default.
• W2025127953 hasConcept C2994186709 @default.
• W2025127953 hasConcept C509974204 @default.
• W2025127953 hasConcept C71924100 @default.
• W2025127953 hasConceptScore W2025127953C126322002 @default.
• W2025127953 hasConceptScore W2025127953C143998085 @default.
• W2025127953 hasConceptScore W2025127953C159110408 @default.
• W2025127953 hasConceptScore W2025127953C168563851 @default.
• W2025127953 hasConceptScore W2025127953C2776256026 @default.
• W2025127953 hasConceptScore W2025127953C2776694085 @default.
• W2025127953 hasConceptScore W2025127953C2779951463 @default.
• W2025127953 hasConceptScore W2025127953C2994186709 @default.
• W2025127953 hasConceptScore W2025127953C509974204 @default.
• W2025127953 hasConceptScore W2025127953C71924100 @default.
• W2025127953 hasIssue "3" @default.
• W2025127953 hasLocation W20251279531 @default.
• W2025127953 hasLocation W20251279532 @default.

• next